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Background
Coronaviruses are enveloped, positive-sense, single-stranded
RNA viruses (27–32 kb genome length) belonging to the
Nidovirales order, which cause infection in the respiratory
and intestinal tract [1]. This family is genetically divided into
four genera, namely alpha, beta, gamma, and delta coronavi-
rus. The first two genera infect mammals, while the latter two
spread the disease to birds [2]. To date, seven coronaviruses
have been identified as human pathogens, including CoV-
229E, CoV-NL63, CoV-HKU1, CoV-OC43, SARS, MERS,
and 2019 novel coronavirus (2019-nCoV). According to phy-
logenetic analysis, the novel coronavirus (SARS-CoV-2) is
located in the beta coronavirus genus. This new coronavirus
causes severe respiratory tract infection and is also highly
contagious [3]. The transmission route of the 2019-nCoV is
mostly through close contact, respiratory droplets, and persis-
tence of the virus on inanimate surfaces [4]. However, some
studies have shown that the fecal–oral route may be a possible
pathway of transmission [5, 6]. The attachment of the virus to
the receptor expressed by cells is an essential step in the oc-
currence of persistent infection in the host. Owing to the struc-
tural similarities between spike surface glycoproteins of 2019-
nCoVand SARS-CoV-2, virus entry is reportedly mediated by
angiotensin-converting enzyme 2 (ACE2) receptor [7].
Furthermore, the tissue tropism and pathogenesis of SARS-
CoV-2 infection would be determined by the distribution of
ACE2 as a receptor. High expression of ACE2 on various
tissues such as respiratory tract cells, the urinary system, and
the testes can account for the involvement of several organs in
SARS-CoV-2 infection [8, 9].
Owing to the lack of adequate treatment and a vaccine, as
well as the asymptomatic incubation period of this emerging
virus, every procedure that could rapidly and accurately detect
infection is important for the management of this disease,
including patient isolation and effective public health surveil-
lance [10]. According to the guidelines published by the
Chinese government, samples suspected to be SARS-CoV-2
should be confirmed by a real-time reverse transcriptase poly-
merase chain reaction (RT-PCR) test [11]. Limitations in
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collecting a specimen from patients and the performance of
laboratory kits mean that quantitative RT-PCR has a high
specificity but a low sensitivity (60–70%) for SARS-CoV-2
detection. The low sensitivity can lead to poor identification of
patients and thus increase the chance of contamination in the
community [12]. Imaging, including computed tomography
(CT), plays a major role in the diagnosis and assessment of
the severity and progression of the disease in COVID-19 in-
fection. An accurate and fast diagnosis of COVID-19-infected
patients through a CT scan is possible with computer-aided
methods such as deep learning [13]. The reported sensitivity
of chest CT has been found to be more than that of RT-PCR
(98% vs 71%, respectively) [14]. As it cannot be excluded that
infected and suspected COVID-19 patients will be referred to
nuclear medicine units, among other health services, special
prevention and protection measures for healthcare workers
and other patients are essential.
Like any similar circumstances, the most logical way to
handle a potential risk is to be informed and systematically
prepared. In line with this, the readiness of units is of great
importance, as this could cause decreased problem. This doc-
ument aims to present precautionary and safety recommenda-
tions at the time of the COVID-19 outbreak for healthcare
workers and to provide the most appropriate information
about personal protective equipment (PPE) for nuclear medi-
cine units.
Personal protective equipment for healthcare
workers
Healthcare workers are at risk of coronavirus infection in
the workplace because of human-to-human transmission
and the contagious nature of viral infection. Thus, preven-
tion and control strategies to reduce secondary infections
among close contacts and healthcare workers are vital.
Previously, international organizations such as the WHO
and the Centers for Disease Control and Prevention
(CDC) produced useful documents about effective strate-
gies for preventing and treating viral infections including
MERS-CoV, Ebola, SARS, and avian flu [15–18]. The
WHO-based guidelines on the most effective preventive
measures for health workers who have been exposed to a
confirmed coronavirus patient in a healthcare facility are
illustrated in Table 1 [19]. Notably, the risk of contagion
for health workers in nuclear medicine units is high be-
cause of the referral of non-symptomatic patients and in-
adequate protection equipment. The medical director and
the security officer should have delivered the right infec-
tion control training and evidence-based framework for
both patients and healthcare workers, based on the accept-
ed prevention and protection guidelines. Health workers
should wear PPE appropriate to their profession or
specialty. This equipment consists of a mask (surgical
and respiratory), gloves, gowns, shoes, head cover, and
eye protection. If the PPE is reusable, it has to be correct-
ly cleaned and decontaminated before and after each use.
Details of PPE usage are elaborated next.
Surgical and respirators masks
There are two main types of masks, “surgical” and “respi-
ratory.” The surgical masks protect against infectious
agents transmitted via droplets of saliva or secretions from
the upper respiratory tract. Nonetheless, protective or re-
spiratory masks also protect against the inhalation of in-
fectious agents transmitted by airborne paths. Individuals
who must wear face masks include every person with
respiratory symptoms such as sneezing, coughing, and
difficulty breathing, people who are caregivers in their
families, and healthcare employees who have been ex-
posed to individuals with confirmed or suspected
COVID-19. Surgical masks are disposable, while respira-
tors can be reused by replacing the filter once it becomes
full. These two types of masks should not be worn for
more than three (for surgical mask) to eight (for respira-
tory mask) hours at a time, according to the manufac-
turers’ guidelines.
The respiratory mask prevents the wearer from inhaling
aerosols, as well as mist or gases, which are health hazards.
It also protects the person from airborne infectious pathogens
such as coronavirus, SARS, or H1N1. In the USA, respirators
are produced based on the NIOSH (National Institute for
Occupational Safety and Health) standard protocols, which
divide them into several classes according the degree of oil
resistance: classes N, R, and P. On the other hand, European
standard EN 149:2001 identifies three classes of disposable
particulate respirators: FFP1, FFP2, and FFP3. Various types
of respiratory masks are shown in Table 2 (http://emag.
medicalexpo.com/which-masks-actually-protect-against-
coronavirus/, http://www.safeticorp.com/data/train_img_
normal /Respiratory_Protect ion.pdf, ht tps: / /www.
rogerwjones.co.uk/tsc28938-ffp1-disposable-mask-10) [20].
Therefore, for the contagious patient, a surgical mask must
be worn as soon as contagion is suspected. For caregivers
caring for a patient with confirmed or suspected coronavirus,
SARS, or H1N1, it is imperative to wear a protective mask of
at least classes FFP2 or FFP3 (classes N, R, or P in the USA)
for the greatest filtration of particles and aerosols. N95 masks
are the most favored mask for health workers in a COVID-19
infected situation (http://guide.medicalexpo.com/choosing-a-
surgical-mask-or-respirator/) [21]. These masks should be
replaced when changing the bowl-shaped mold and the soiled
filter. Before touching the mask, hands should be washed with
soap and water for at least 20 s, then dried with a clean paper
towel.
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Gloves
Gloves are made of different materials and differ accord-
ing to the type of work undertaken. Patients, caregivers,
and healthcare workers must use gloves to protect them-
selves from infections during examinations. Details of the
most appropriate professional gloves for healthcare
wo rke r s a r e summar i z ed i n Tab l e 3 (h t t p s : / /
avacaremedical.com/medical-gloves-guide, https://
mercatormedical.eu/products/gloves) [22], along with
their properties. The first stage in determining which
type of gloves would be suitable is identifying the
dangers and the corresponding hand protec t ion
measures. The best gloves for healthcare workers are,
first, latex and, second, nitrile [20].
Wearing a face mask and gloves cannot definitely block
infections in any of these circumstances and should be com-
bined with other PPE and regimes, such as hand hygiene,
maintaining a distance from people with symptoms, and re-
spiratory hygiene (or cough etiquette). The correct order for
donning and removing PPE is also important. The relevant
steps are shown in Figs. 1 and 2 (https://www.cdc.gov/HAI/
pdfs/ppe/ppeposter1322.pdf). Perform hand hygiene
immediately after removing all PPE.
Table 1 Recommended personal protective equipment (PPE) for dealingwith patients with COVID-19 disease, according to the setting, personnel, and
type of activity (WHO recommendations)
he
al
th
-c
ar
e w
or
ke
r
Inpatient Facalities
Patient room Direct Care to Covid-19 patients
Medical Mask, Gown, Gloves, Eye 
Protection
other area of patient transit 
(e.g wards,corridors)
Any activity that dose not involve contact 
with COVID-19 patients
NNNo PPE required
Triage
Preliminary Screening not involving direct 
contact
Minimum distance at least 1 m,  No 
PPE required
Administrative area
Administrative task that do not involve 
contact with COVID-19 patient
No PPE required
Outpatient Facalities
Consulation room
Physical examination of patients with 
respiratory syndrome
Medical Mask, Gown, Gloves, Eye 
Protection
Physical examination of patients without 
respiratory syndrome
ppPPPE accordance to standard 
precations and risk assesment 
Administrative area Administrative task No PPE required
Triage
Preliminary screening not involving direct 
contact
Minimum distance at least 1m, No PPE 
required
Community (Home) Temporary isolation area Providing direct care or assitant to a COVID-
19 patient at home
Medical Mask,Gown, Gloves, Eye 
Protection 
Point of Entry
Temporary isolation Area
Assisting passenger being transported to a 
healthcare facility
Medical mask, Glowes, Gloves, Eye 
Protection  
Ambulance transfer or 
transfer vehicle
Transporting suspected COVID-19 patients 
to the referral healthcare facality
Medical mask, Gown,Glows, Eye 
protection 
Table 2 Different types of respirator mask to be used for personal protective equipment
Respirator types Property
FFP1 Suitable for particles larger than 5 μm, 80% aerosol filtration maximum, and 22%
leakage to the inside, mainly used as a dust mask (home renovations and various types of work)
FFP2 Suitable for particles between 2 and 5 μm with a minimum 94% filtration and
maximum 8% leakage to the inside, mainly used in construction, agriculture, and healthcare
professionals against influenza viruses. They are currently used for protection against the coronavirus
FFP3 The most filtering mask of the FFPs, suitable for particles smaller than 2 μm with a minimum 99%
filtration and maximum 2% leakage to the inside, using against very fine particles such as asbestos
N class No oil resistance. A distinction is made between N95, N99, and N100 suitable for particles larger
than 0.3 μm, and the number after the letter indicates the percentage of filtration of suspended particles
R class Resistant to oil for up to 8 hours. Similar to the N class, a division is made between R95, R99, and R100,
suitable for particles larger than 0.3 μm
P class Class P: a completely oil-resistant mask. There are also P95, P99, and P100
FFP, filtering facepiece
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General recommendations for nuclear
medicine units
The two principal measures to prevent transmission of infec-
tious diseases, namely elimination or removing the risk phys-
ically and substitution of the risk, are not applicable to the
healthcare setting. Nevertheless, contagion can be reduced
by decreasing exposure to transmissible respiratory particles
in these units. Therefore, strategies including environmental
hygiene, administrative regulations, high work performance,
and the correct use of PPE are essential to prevent the spread
of infections in a healthcare setting. It has shown that the
factors that increase the risk of death in COVID-19 patients
include cardiovascular disease (10.5%), diabetes (7.3%),
chronic respiratory disease (6.3%), high blood pressure
(6%), cancer (5.6%), and certain other underlying diseases
(0.9%) [23]. It is recommended that health workers with these
risk factors should stop work immediately and take time off
away from the unit. Moreover, personnel must be aware of the
latest COVID-19 information and recommendations and
should check themselves for any signs of disease (subjective
fever, cough, or difficulty breathing) before presenting to the
Table 3 The most applicable medical gloves
Glove Type Advantages Protection Level
Latex suitable for biological hazards 
and water-based liquids.
Time usage: 16 h
Bacteria, Viruses (<1% 
viral penetration rate )
Nitrile good versatile, general-use 
gloves,
puncture resistant, greater 
protection, chemical resistant
Time usage: 8 h
chemical materials 
such as Solvents, 
Petroleum oils, 
Gasoline, Greases,
Some acids and bases/ 
viruses 
Vinyl cost-effective, latex-free, soft, 
standard protection, less 
durable well suited for the 
majority of clinical work
chemical material such 
as acid and alkali 
material /viruses
Nylon relative protection, cost-
effective, no allergic
No viral protection
Fig. 1 Steps for putting on PPE
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facility, as well as informing their supervisor about their con-
dition. They must be monitored for fever and respiratory syn-
drome twice daily. The most important precautions relating to
workers carrying out imaging in nuclear medicine units are
discussed next (http://www.cidrap.umn.edu/covid-19/
information-employers/healthcare, https://www.cdc.gov/
coronavirus/2019-ncov/hcp/respirator-use-faq.html) [21,
23–26].
Planning and coordination of imaging and admission of
patients
& As far as possible, do not perform nuclear medicine
imaging for patients with fever and respiratory symp-
toms. Take a history from all patients (fever, cough, or
difficulty breathing) and monitor these symptoms in
admission processing. Check temperature regularly;
if there is fever, imaging must be delayed and
rescheduled while additional tests are conducted to
determine the probability of COVID-19 infection.
Nuclear medicine treatment of suspected or verified
COVID-19 patients should be delayed as much as
possible.
& Postpone non-urgent thyroid ultrasound examination. If it
must be performed, use separate portable thyroid ultra-
sound equipment in a care unit in which COVID-19-
infected patients are isolated. This device should not be
used for other non-infected patients.
& Therapeutic procedures with radiopharmaceuticals (i.e.,
differentiated thyroid cancer, neuroendocrine tumors, met-
astatic prostate cancer, metastatic castration resistance
prostate cancer, radiation) and with radioactive medical
devices (i.e., SIRT) should be postponed, according to
the clinical need.
& If it can be avoided, do not perform a ventilation scan.
& In order to minimize exposure among patients and health
workers, all scintigraphy orders should be performed after
careful examination by the clinician and when the results
of other pathological and clinical tests are available.
& Consider every strategy that results in minimizing face-to-
face contact. For example, the entire processing of admis-
sions must be done carefully before patients arrive in the
imaging units (phone-based communication or not in-
person referral).
& Try to make regular appointments for imaging and carry
out the procedure only at the allocated time. If the timeta-
ble has changed, it can be suggested that patients wait at
home or in their car.
& As much as possible, portable imaging in emergency
wards should be performed in a room with appropriate
ventilation.
& For cases admitted to hospitals, before referring the patient
to the nuclear medicine unit, the relevant ward should
coordinate with the imaging unit regarding probable
infection.
Management of patients and environmental hygiene
Managing patients
& Maintain a spatial distance of at least 1 m between non-
infected, potential, and verified infected COVID-19 pa-
tients and also between patients and health workers to
decrease the transmission of pathogens.
& Consider the use of patient cohorting, such as scheduling
potential infected and confirmed infected patients at the
same time for examination or imaging and non-infected
patients at a different time, to reduce the transmission of
COVID-19 pathogens to healthcare workers and other
non-infected patients.
Fig. 2 Steps for removing PPE
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& Patients in treatment rooms, whether non-infected,
potential infected, or confirmed infected, must not
be allowed to visit one another or walk in a hallway
of the treatment unit.
& After performing imaging, patients and their companions
should be asked to leave the units quickly to prevent
crowding and more transmission of infection.
& Attendants of patients should not enter the imaging room,
except in the case of children and disabled or vulnerable
adults, who may be accompanied by at most one person.
Environmental hygiene
& Provide visuals or infographics (posters or signs) advertis-
ing the correct use of PPE, including disposable outer-
wear, gloves, and a surgical mask. Patients must be trained
to cover their mouth and nose when coughing or sneezing
with a tissue, medical mask, a sleeve, or a bent elbow, to
decrease the dispersion of respiratory droplets containing
potentially infectious pathogen particles.
& Clearly instruct patients in the “hot” waiting rooms not to
sit closer than 1 m to each other.
& Asepsis and cleaning of the wards must be done regularly,
with special attention to toilets, doorknobs, reception
desks, keyboards, computer mice, and imaging equip-
ment, where hand contact is more likely.
& Wards should be cleaned with solutions containing chlo-
rine or hydrogen peroxide. If possible, use ultraviolet
(UV) germicidal irradiation for sterilizing of the systems
at least once a day.
& Hand cleaning using an alcohol-based hand sanitizer (60–
95% alcohol) should be accomplished before and after
putting on or removing PPE.
& All waste receptacles must have a hinged lid.
& After performing imaging of infected or suspected
COVID-19 patients, all touched surfaces must be
disinfected frequently.
& The bed covering must be changed after each scan.
Place waste receptacles in the hallway and waiting
room for patients and personnel to dispose of PPE
easily if required.
& After performing the scan, the device should be
disinfected according to the manufacturer’s instructions.
& Disposable paper cups should be laid out separately, not
stacked, in a defined place, so that single cups may be
removed without touching the others.
& Stick signs to the door or outer wall of the units near the
entrance to the healthcare section to warn workers that
PPE must be used.
& Make sure that any sink is equipped with soap and dispos-
able paper towels.
& Put alcohol-based hand sanitizers in the hallway, exami-
nation, and waiting rooms.
& The hand control of the device should be covered (using a
special probe cover, gloves, or cellophane), and its surface
should be wiped with an alcoholic antiseptic.
& It should be installed appropriate air-handling systems in
the facilities and ensure good airflow within units, as this
can dramatically reduce the risk of nosocomial transmis-
sion of some coronavirus strains.
Personal protective equipment
& All staff (technicians, nurses, service personnel, and other
health workers) should be trained in the correct use of PPE,
including the proper sequences for putting on and removing
PPE and decontamination of infected equipment.
& All staff in the nuclear medicine unit (physicians, nurses,
technicians, receptionists, service personnel) should have
appropriate protection equipment (mask, gown, and
gloves), and the hospital management, head of the unit,
or technical officer is required to equip staff with full-
zipped clothing (standard protection), goggles, at least
N95 filtering facepiece respirators, and gloves.
& Patients must wear a surgical mask before being referred
to the nuclear medicine unit. Gloves are suggested and
hand cleaning is mandatory. Suspected or verified
COVID-19 patients must have full protection.
& All nuclear medicine units should have a separate external
area for supplying surgical masks, hand cleaning lotions,
and gloves to every person who enters the unit. Everyone
must be considered a patient in the latency period.
& A checkpoint at the hospital entrance should be in place to
monitor the body temperature of patients, workers, and
visitors. Few questions should also be asked whether the
person had sore throat, cough, or have been in contact with
infected persons. This control should be repeated when a
patient enters the nuclear medicine unit. In countries
where it is accepted, the patients who refer to the nuclear
medicine units should fill out a verified online screening
test for coronavirus infection and show the results of the
online tests to the checkpoint at the unit/hospital entrance.
Conclusion
The pandemic SARS-CoV-2 disease is spreading rapid-
ly. Healthcare workers and others must take protective
and preventive measures to reduce the probability of
contagion. All staff in nuclear medicine units must fol-
low the national and local official recommendations and
guidelines to lower the risk of transmission. Recording
and assessing all our experiences and lessons about
COVID-19 daily will be a valuable exercise, helping
to guide the management of the coronavirus pandemic.
Case designations are dynamic, and consequently, front-
line doctors are strongly urged to seek updates from
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public health and infection control authorities as our
understanding of this disease matures. Onemore important
point that we should not forget in this situation is this fact that this
situation confines people to a small area and limits normal activ-
ity out of doors, which may lead to increased stress levels, rest-
lessness, and the adverse consequences of physical inactivity.
Psychological and behavioral supports could be helpful for the
reduction of anxiety and negative moods, which could be impor-
tant for increasing resilience during this disease outbreak.
Finally, it should be kept in mind that like other
similar conditions, the most proper way to deal with
any crisis is to be widely prepared. Up to now, it may
believe that the performance of the healthcare system in
nuclear medicine units is limited to radiation issues.
This fact intensifies the necessity of nuclear medicine
unit preparedness before an infection outbreak in addi-
tion to radiation accident. The development of an indi-
vidualized management model for each nuclear medicine
unit based on staffs, instruments, kind of services,
crowding, physical space, hospital base unit, or outpa-
tient clinic that could consider all managerial aspects of
a crisis is of pivotal importance. The proposed response
mode should have internal and systemic integrity and
coherence among the included items in two intra- and
inter-unit management categories. Besides, continuous
training of different occupational staffs are among the
key parameters in keeping the readiness and appropriate
response of units to rare but extremely important prob-
able infection outbreak.
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